局限性前列腺癌确定性治疗的延迟:我们了解什么?
本文为叙述性综述,总结前瞻性与回顾性研究中治疗延迟对局限性前列腺癌肿瘤学结局影响的数据。文章指出初始活检后额外检查、专科转诊及心理因素常导致延迟,并提及疫情期间发布的放疗与根治性前列腺切除术时机建议缺乏详细依据。
要点
- 初始前列腺活检后额外检查、专科转诊及心理因素是治疗延迟最常见原因。
- 疫情期间发布了局限性前列腺癌放疗与根治性前列腺切除术时机的建议,但无详细依据。
- 缺乏专门回答治疗时机问题的I级证据,本文综述前瞻性与回顾性研究数据。
核心结论
- 在缺乏专门回答治疗时机问题的I级证据情况下,本文通过叙述性综述总结前瞻性与回顾性研究中治疗延迟对局限性前列腺癌肿瘤学结局影响的数据。
研究设计与样本
- 叙述性综述,总结前瞻性与回顾性研究中关于治疗延迟对局限性前列腺癌肿瘤学结局影响的数据。
主要发现
- 初始前列腺活检后额外检查、专科转诊及心理因素是治疗延迟最常见的原因。
局限性
- 缺乏专门回答治疗时机问题的I级证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Delays in the work-up and definitive management of patients with prostate cancer are common, with logistics of additional work-up after initial prostate biopsy, specialist referrals, and psychological reasons being the most common causes of delays. During the COVID-19 pandemic and the subsequent surges, timing of definitive care delivery with surgery or radiotherapy has become a topic of significant concern for patients with prostate cancer and their providers alike. In response, recommendations for the timing of definitive management of prostate cancer with radiotherapy and radical prostatectomy were published but without a detailed rationale for these recommendations. While the COVID-19 pandemic is behind us, patients are always asking the question: "When should I start radiation or undergo surgery?" In the absence of level I evidence specifically addressing this question, we will hereby present a narrative review to summarize the available data on the effect of treatment delays on oncologic outcomes for patients with localized prostate cancer from prospective and retrospective studies.
引用
- Mohamad O, Li YR, Feng F, et al. Delayed definitive management of localized prostate cancer: what do we know? Prostate Cancer Prostatic Dis. 2024. PMID: 39128937. doi:10.1038/s41391-024-00876-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。